Charles W. Newton - Director at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Charles W. Newton since 12 Mar 2025

Holdings reported by Charles W. Newton for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 13,215 $227,826 $17.24 09 Mar 2026 Direct
Stock Option (Right to Buy) 14,788 09 Mar 2026 Direct Common Stock

Transactions reported by Charles W. Newton for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.